Peter Malfertheiner mostly deals with Internal medicine, Gastroenterology, Helicobacter pylori, Surgery and Pancreatitis. Within one scientific family, Peter Malfertheiner focuses on topics pertaining to Pathology under Internal medicine, and may sometimes address concerns connected to Stomach. His Gastroenterology research includes themes of Prospective cohort study, Reflux, GERD and Esophageal disease.
His Helicobacter pylori research incorporates themes from Amoxicillin and Antibacterial agent. His study on Double-balloon enteroscopy is often connected to In patient as part of broader study in Surgery. His work deals with themes such as Pancreatic disease, Pancreas, Radiation therapy, Radiology and Acute pancreatitis, which intersect with Pancreatitis.
His primary areas of study are Internal medicine, Gastroenterology, Helicobacter pylori, Cancer and Pathology. Peter Malfertheiner combines subjects such as Endocrinology and Oncology with his study of Internal medicine. His study in the fields of Stomach, Intestinal metaplasia and Pancreatitis under the domain of Gastroenterology overlaps with other disciplines such as In patient.
The various areas that he examines in his Pancreatitis study include Radiology and Acute pancreatitis. His Helicobacter pylori study integrates concerns from other disciplines, such as Immunology and Gastric mucosa. His Clarithromycin study incorporates themes from Amoxicillin and Metronidazole.
His scientific interests lie mostly in Internal medicine, Gastroenterology, Helicobacter pylori, Cancer and Oncology. He focuses mostly in the field of Internal medicine, narrowing it down to matters related to Surgery and, in some cases, Adverse effect. Peter Malfertheiner interconnects Prospective cohort study, Reflux and Biopsy in the investigation of issues within Gastroenterology.
His Helicobacter pylori study combines topics in areas such as CagA, Serology, Gastric mucosa and Microbiology. Peter Malfertheiner mostly deals with Colorectal cancer in his studies of Cancer. His work in the fields of Sorafenib and Liver cancer overlaps with other areas such as In patient.
Peter Malfertheiner spends much of his time researching Internal medicine, Gastroenterology, Helicobacter pylori, Cancer and Surgery. Peter Malfertheiner frequently studies issues relating to Oncology and Internal medicine. His Gastroenterology research is multidisciplinary, incorporating perspectives in Esophagus, Prospective cohort study and Esophagogastroduodenoscopy.
The study incorporates disciplines such as Immunology and Stomach, Antrum, Gastric mucosa in addition to Helicobacter pylori. He has included themes like Cancer research and Incidence in his Cancer study. His study looks at the relationship between Surgery and fields such as Tolerability, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Peter Malfertheiner;Francis Megraud;John Atherton;Anthony T R Axon.
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
P. Malfertheiner;F. Mégraud;C. O'Morain;A. P. S. Hungin.
Alimentary Pharmacology & Therapeutics (2002)
Current European concepts in the management of Helicobacter pylori infection the Maastricht Consensus Report
P. Malfertheiner;F. Megraud;C. O'morain;D. Bell.
European Journal of Gastroenterology & Hepatology (1997)
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
James K.Y. Hooi;Wan Ying Lai;Wee Khoon Ng;Wee Khoon Ng;Michael M.Y. Suen.
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial.
Rainer Isenmann;Michael Rünzi;Martina Kron;Stefan Kahl.
European consensus conference on faecal microbiota transplantation in clinical practice
Giovanni Cammarota;Gianluca Ianiro;Herbert Tilg;Mirjana Rajilić-Stojanović.
Diagnosis of Helicobacter pylori infection with a new non-in vasive antigen-based assay
Dino Vaira;Peter Malfertheiner;Francis Megraud;Anthony Tr Axon.
The Lancet (1999)
Hepatocellular carcinoma - epidemiological trends and risk factors.
Kerstin Schütte;Jan Bornschein;Peter Malfertheiner.
Digestive Diseases (2009)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Peter Malfertheiner;Franco Bazzoli;Jean-Charles Delchier;Krysztof Celiñski.
The Lancet (2011)
OLGA staging for gastritis: a tutorial
M Rugge;P Correa;F Di Mario;Emad Munir El-Omar.
Digestive and Liver Disease (2008)
(Impact Factor: 3.421)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: